Genetic counseling for families with inherited susceptibility to breast and ovarian cancer

B. B. Biesecker, M. Boehnke, K. Calzone, D. S. Markel, J. E. Garber, F. S. Collins and B. L. Weber
Department of Human Genetics, University of Michigan School of Medicine, Ann Arbor.

Efforts are under way to isolate a gene (BRCA1) on chromosome 17q12-21. Mutations in this gene predispose women to breast and ovarian cancer. Women with germline mutations in BRCA1 are estimated to have an 85% lifetime risk of developing breast cancer and an increased but as yet undetermined risk of ovarian cancer. It is estimated that one in 200 to 400 American women may be carriers of BRCA1 mutations. We have identified several families that show linkage between breast and/or ovarian cancer and genetic markers that flank BRCA1. It is now possible, within these linked families, to prospectively identify family members likely to be carrying BRCA1 mutations. Because of profound and immediate clinical ramifications, we offered to provide this information to one such extended family. To provide information to this family, we developed a protocol to address the many issues that arise in the delivery of these services. Although testing for BRCA1 mutation carriers is currently limited to very rare families being analyzed for research purposes, this experience presages the complexities of the much larger scale availability of population screening for BRCA1 mutations, which is likely to become a reality in the next few years.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genetic Counseling and Testing for Common Hereditary Breast Cancer Syndromes: A Paper from the 2007 William Beaumont Hospital Symposium on Molecular Pathology
Allain
J. Mol. Diagn. 2008;10:383-395.
ABSTRACT | FULL TEXT  

Short-Term Impact of Cancer Prevention and Screening Activities on Quality of Life
Cullen et al.
JCO 2004;22:943-952.
ABSTRACT | FULL TEXT  

"Genetic Exceptionalism" in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests
Green and Botkin
ANN INTERN MED 2003;138:571-575.
ABSTRACT | FULL TEXT  

Impact of BRCA1/BRCA2 Mutation Testing on Psychologic Distress in a Clinic-Based Sample
Schwartz et al.
JCO 2002;20:514-520.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Microsatellite Instability Screening as a Method for Detecting Hereditary Nonpolyposis Colorectal Cancer
Ramsey et al.
ANN INTERN MED 2001;135:577-588.
ABSTRACT | FULL TEXT  

An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling
Metcalfe et al.
J. Med. Genet. 2000;37:866-874.
ABSTRACT | FULL TEXT  

Testing Adolescents for a Hereditary Breast Cancer Gene (BRCA1): Respecting Their Autonomy Is in Their Best Interest
Elger and Harding
Arch Pediatr Adolesc Med 2000;154:113-119.
ABSTRACT | FULL TEXT  

Alzheimer's disease and symptom-seeking
Hodgson et al.
AM J ALZHEIMERS DIS OTHER DEMEN 1999;14:364-374.
ABSTRACT  

Intention to Learn Results of Genetic Testing for Hereditary Colon Cancer
Vernon et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:353-360.
ABSTRACT | FULL TEXT  

Attitudes and Interest in Genetic Testing for Breast and Ovarian Cancer Susceptibility in Diverse Groups of Women in Western Washington
Durfy et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:369-375.
ABSTRACT | FULL TEXT  

High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects
Goelen et al.
J. Med. Genet. 1999;36:304-308.
ABSTRACT | FULL TEXT  

Attitudes, Knowledge, and Risk Perceptions of Women With Breast and/or Ovarian Cancer Considering Testing for BRCA1 and BRCA2
Bluman et al.
JCO 1999;17:1040-1040.
ABSTRACT | FULL TEXT  

Risk Communication in Genetic Testing for Cancer Susceptibility
Croyle and Lerman
J Natl Cancer Inst Monogr 1999;1999:59-66.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus Type 1-Like DNA Sequences and Immunoreactive Viral Particles with Unique Association with Breast Cancer
Rakowicz-Szulczynska et al.
CVI 1998;5:645-653.
ABSTRACT | FULL TEXT  

Perceived and Actual Breast Cancer Risk: Optimistic and Pessimistic Biases
Skinner et al.
J Health Psychol 1998;3:181-193.
ABSTRACT  

Commentary: Risks and Benefits, Testing and Screening, Cancer, Genes and Dollars
Kodish
J Law Med Ethics 1997;25:252-255.
 

Genetic Screening for Breast Cancer
Rosenblatt et al.
NEJM 1996;334:1200-1201.
FULL TEXT  

BRCA1 -- Lots of Mutations, Lots of Dilemmas
Collins
NEJM 1996;334:186-188.
FULL TEXT  

The future of breast and ovarian cancer clinics
Campbell et al.
BMJ 1995;311:1584-1585.
FULL TEXT  

When Should Preventive Treatment Be Paid for by Health Insurance?
Annas
NEJM 1994;331:1027-1030.
FULL TEXT  

Generic Consent for Genetic Screening
Elias and Annas
NEJM 1994;330:1611-1613.
FULL TEXT